Concepedia
Statistics
Publications
30
Citations
3.2K
H-Index
22
Active since
1998
Affiliations
Goethe University Frankfurt(Current)
Columbia University Irving Medical Center
AstraZeneca (United Kingdom)
University Hospital of Lausanne
Samsung Medical Center
Urban Scheuring is an author at Goethe University Frankfurt specializing in medicine, oncology, and cancer immunotherapy.
Publications per year
1998–2022
Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non–Small Cell Lung Cancer
Naiyer A. Rizvi, Byoung Chul Cho, Niels Reinmuth et al. · JAMA Oncology · 2020 · 628 citations · Full text
Medicine, Oncology, Pharmacotherapy +17
Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia
Monika Brüggemann, Thorsten Raff, Thomas Flohr et al. · Blood · 2005 · 537 citations
Medicine, Hematology, Oncology +16
Randomized Phase II Trial of First-Line Treatment With Sorafenib Versus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma
Bernard Escudier, Cezary Szczylik, Thomas E. Hutson et al. · Journal of Clinical Oncology · 2009 · 491 citations
Medicine, Oncology, Pharmacology +15
Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)
Michael Stadler, Martin Bornhäuser, Gesine Bug et al. · Blood · 2005 · 199 citations · Full text
Medicine, Molecular Biology, Oncology +13
ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer
David Planchard, Niels Reinmuth, Jürgen R. Fischer et al. · Annals of Oncology · 2020 · 161 citations · Full text
Medicine, Oncology, Pharmacotherapy +16
1–5 of 30